Susan Thibeault, PhD, CCC-SLP

Professor

  • Diane M. Bless Endowed Chair in Otolaryngology
  • Vice Chair of Research, Department of Surgery
  • UW Health Medical Director of Speech & Hearing Services
  • Division of Otolaryngology-Head & Neck Surgery

thibeault@surgery.wisc.edu
(608) 263-0192

Wisconsin Institutes for Medical Research (WIMR) BLDG. 1485
1111 Highland Avenue
Madison, WI 53705-2275

Education

  • BS, University of Western Ontario, Biology, London, Ontario, Canada
  • MS, Communication Disorders, State University of New York, Buffalo, NY
  • PhD, Communication Disorders, University of Wisconsin, Madison, WI

Clinical Specialties

Susan Thibeault, PhD, CCC–SLP, is the Medical Director of the Speech & Hearing Services at UW Health and the Diane M. Bless Endowed Professor in the Department of Surgery, Division of Otolaryngology-Head & Neck Surgery, at the University of Wisconsin–Madison.

Research Interests

Dr. Thibeault is the Vice Chair of Research in the Department of Surgery. She received her PhD from the University of Wisconsin–Madison. Her NIDCD funded research efforts are primarily in the areas of vocal fold mucosa biology encompassing regenerative medicine, immunology and development.

Specific to WiSOR affiliated health services research, Dr. Thibeault is the Principal Investigator for the University of Wisconsin–Madison Voice and Swallow Outcomes Database. This is a disease specific database that has health-related data including long-term data from more than 5000 patients who have been seen at the University of Wisconsin–Madison.

Dr. Thibeault’s Lab >>

Dr. Susan Thibeault and Dr. Vlasta Lungova were awarded a five-year, $2.7 million research grant from the National Institute on Deafness and Other Communication Disorders. Their study will focus on vocal fold epithelial stem cells and their role in maintaining the structure and function of the vocal fold epithelium. Read more here.

Recent Publications

  • Economic Burden of Induced Laryngeal Obstruction in Adolescents and Children.
    Fujiki RB, Lunga T, Francis DO, Thibeault SL
    Laryngoscope 2024 Jan 17;
    [PubMed ID: 38230958]

  • The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
    King RE, Rademacher J, Ward-Shaw ET, Hu R, Bilger A, Blaine-Sauer S, Spurgeon ME, Thibeault SL, Lambert PF
    Laryngoscope 2023 Dec 12;
    [PubMed ID: 38084790]

  • Examining therapy duration in adults with induced laryngeal obstruction (ILO).
    Fujiki RB, Fujiki AE, Thibeault SL
    Am J Otolaryngol 2024; 45(1): 104094
    [PubMed ID: 37948819]

  • Factors influencing behavioral cough suppression therapy in children with nonspecific chronic cough.
    Fujiki RB, Wright ML, Fujiki AE, Thibeault SL
    Pediatr Pulmonol 2023 Dec; 58(12): 3466-3477
    [PubMed ID: 37737562]

  • Clinical Profiles of Children and Adolescents With Induced Laryngeal Obstruction (ILO) and Exercise Induced Laryngeal Obstruction (EILO).
    Fujiki RB, Olson-Greb B, Thibeault SL
    Ann Otol Rhinol Laryngol 2024 Feb; 133(2): 136-144
    [PubMed ID: 37534611]

All Publications on PubMed